In our study, the ReDisX framework validates the potential of GZMB as a subpopulation differentiation marker within the same disease, e.g., under expression of GZMB in cluster 1 of RA patients and overexpression of GZMB in clusters 2 and 3 of RA patients. The gene discussed is GZMB; the disease is rheumatoid arthritis.